Skip to Main Content

Author Details

Victoria A Feher
University of California San Diego
1989
39
27
Christopher Churas (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
35044775In Vitro and In Vivo Inhibition of the <i>Mycobacterium tuberculosis</i> Phosphopantetheinyl Transferase PptT by Amidinoureas.J Med Chem2022
30606449Mechanisms for Benzene Dissociation through the Excited State of T4 Lysozyme L99A Mutant.Biophys J2019
31257108Continuous Evaluation of Ligand Protein Predictions: A Weekly Community Challenge for Drug Docking.Structure2019
29204945D3R Grand Challenge 2: blind prediction of protein-ligand poses, affinity rankings, and relative binding free energies.J Comput Aided Mol Des2018
30380198The Role of Bridging Water and Hydrogen Bonding as Key Determinants of Noncovalent Protein-Carbohydrate Recognition.ChemMedChem2018
28169164Structure-based design and SAR development of 5,6-dihydroimidazolo[1,5-f]pteridine derivatives as novel Polo-like kinase-1 inhibitors.Bioorg Med Chem Lett2017
27074285Emerging Computational Methods for the Rational Discovery of Allosteric Drugs.Chem Rev2016
27760351Capturing Invisible Motions in the Transition from Ground to Rare Excited States of T4 Lysozyme L99A.Biophys J2016
27696240D3R grand challenge 2015: Evaluation of protein-ligand pose and affinity predictions.J Comput Aided Mol Des2016
27839918Discovery of TAK-659 an orally available investigational inhibitor of Spleen Tyrosine Kinase (SYK).Bioorg Med Chem Lett2016
27050687Outcome of the First wwPDB/CCDC/D3R Ligand Validation Workshop.Structure2016
25330975Molecular docking to flexible targets.Methods Mol Biol2015
26300708Gaussian Accelerated Molecular Dynamics: Unconstrained Enhanced Sampling and Free Energy Calculation.J Chem Theory Comput2015
24490002Computation-guided discovery of influenza endonuclease inhibitors.ACS Med Chem Lett2014
24667124Computational approaches to mapping allosteric pathways.Curr Opin Struct Biol2014
23664874Discovery of TAK-960: an orally available small molecule inhibitor of polo-like kinase 1 (PLK1).Bioorg Med Chem Lett2013
23935908A 3-dimensional trimeric β-barrel model for Chlamydia MOMP contains conserved and novel elements of Gram-negative bacterial porins.PLoS One2013
22384182Structural characterisation of Tpx from Yersinia pseudotuberculosis reveals insights into the binding of salicylidene acylhydrazide compounds.PLoS One2012
20621728Structure-based design and synthesis of pyrrole derivatives as MEK inhibitors.Bioorg Med Chem Lett2010
15149667Structure-based design, synthesis, and antimicrobial activity of purine derived SAH/MTA nucleosidase inhibitors.Bioorg Med Chem Lett2004
14667220Structure-based design, synthesis, and antimicrobial activity of indazole-derived SAH/MTA nucleosidase inhibitors.J Med Chem2003
14677945Application of NMR SHAPES screening to an RNA target.J Am Chem Soc2003
11152601The DNA-binding domain in the Bacillus subtilis transition-state regulator AbrB employs significant motion for promiscuous DNA recognition.J Mol Biol2001
11101897Novel DNA binding domain and genetic regulation model of Bacillus subtilis transition state regulator abrB.Nat Struct Biol2000
10094672Two-component signal transduction in Bacillus subtilis: how one organism sees its world.J Bacteriol1999
10411754Alanine mutants of the Spo0F response regulator modifying specificity for sensor kinases in sporulation initiation.Mol Microbiol1999
10421374Millisecond-timescale motions contribute to the function of the bacterial response regulator protein Spo0F.Nature1999
9716389Sequence requirements for stabilization of a peptide reverse turn in water solution--proline is not essential for stability.Eur J Biochem1998
9514755Generation of ligand binding sites in T4 lysozyme by deficiency-creating substitutions.J Mol Biol1998
9540996Identification of communication networks in Spo0F: a model for phosphorylation-induced conformational change and implications for activation of multiple domain bacterial response regulators.FEBS Lett1998
9843420Characterization of interactions between a two-component response regulator, Spo0F, and its phosphatase, RapB.Biochemistry1998
9254596High-resolution NMR structure and backbone dynamics of the Bacillus subtilis response regulator, Spo0F: implications for phosphorylation and molecular recognition.Biochemistry1997
8646537Access of ligands to cavities within the core of a protein is rapid.Nat Struct Biol1996
85280781H, 15N, and 13C backbone chemical shift assignments, secondary structure, and magnesium-binding characteristics of the Bacillus subtilis response regulator, Spo0F, determined by heteronuclear high-resolution NMR.Protein Sci1995
7966293Stabilization of a type VI turn in a family of linear peptides in water solution.J Mol Biol1994
24190783Aspartyl phosphates in the regulatory control of bacterial response.Amino Acids1994
8518279Peptide models of protein folding initiation sites. 1. Secondary structure formation by peptides corresponding to the G- and H-helices of myoglobin.Biochemistry1993
2002540Mapping the anatomy of the immunodominant domain of the human immunodeficiency virus gp41 transmembrane protein: peptide conformation analysis using monoclonal antibodies and proton nuclear magnetic resonance spectroscopy.J Virol1991
2787756Conformation of a T cell stimulating peptide in aqueous solution.FEBS Lett1989
  • 1 - 39 of 39

Recommended Authors

University of California San Francisco
Career Start Year 2002
Number of shared co-authors 1
Albert Einstein College of Medicine
Career Start Year 1999
Number of shared co-authors 4
Department of Pharmaceutical Chemistry, University of California san francisco
Career Start Year 1999
Number of shared co-authors 9
University of Connecticut School of Medicine
Career Start Year 1995
Number of shared co-authors 2
Harwell Science & Innovation Campus
Career Start Year 1994
Number of shared co-authors 2
Laufer Center for Physical and Quantitative Biology, Stony Brook University
Career Start Year 1994
Number of shared co-authors 1
University of Texas Southwestern Medical Center
Career Start Year 1993
Number of shared co-authors 1
Miami University
Career Start Year 1993
Number of shared co-authors 6
Imperial College London
Career Start Year 1993
Number of shared co-authors 2
National Institute of Diabetes and Digestive and Kidney Diseases
Career Start Year 1991
Number of shared co-authors 11
Bridge Institute, University of Southern California
Career Start Year 1991
Number of shared co-authors 1
Center for Molecular Biology (ZMBH), Heidelberg University
Career Start Year 1989
Number of shared co-authors 1
Hospital for Sick Children
Career Start Year 1989
Number of shared co-authors 2
Albert Einstein College of Medicine
Career Start Year 1988
Number of shared co-authors 5
Columbia University
Career Start Year 1986
Number of shared co-authors 6
Institut Pasteur
Career Start Year 1986
Number of shared co-authors 11
Institute of Systems, The University of Liverpool
Career Start Year 1984
Number of shared co-authors 2
Department of Pharmaceutical Chemistry, University of California san francisco
Career Start Year 1982
Number of shared co-authors 0
The University of Sheffield
Career Start Year 1982
Number of shared co-authors 2
University of Pittsburgh
Career Start Year 1980
Number of shared co-authors 2
Sackler School of Medicine, Tel Aviv University
Career Start Year 1980
Number of shared co-authors 10
Utrecht University
Career Start Year 1979
Number of shared co-authors 3
University of California berkeley
Career Start Year 1976
Number of shared co-authors 1
Rice University
Career Start Year 1974
Number of shared co-authors 8
University of Michigan ann arbor
Career Start Year 1974
Number of shared co-authors 1
CUNY Advanced Science Research Center
Career Start Year 1971
Number of shared co-authors 2
Albert Einstein College of Medicine
Career Start Year 1969
Number of shared co-authors 0
University of California berkeley
Career Start Year 1967
Number of shared co-authors 5
University of California San Francisco
Career Start Year 1965
Number of shared co-authors 0
Harvard University
Career Start Year 1959
Number of shared co-authors 3

Collaborators

University of California
Co-authored papers 11
The State University of New Jersey
Co-authored papers 4
University of California San Diego
Co-authored papers 3
University of California
Co-authored papers 3
XtalPi Inc.
Co-authored papers 3
The State University of New Jersey
Co-authored papers 3
University of California
Co-authored papers 3
The State University of New Jersey
Co-authored papers 3
University of Pittsburgh
Co-authored papers 2
Kaiser Permanente San Francisco Medical Center
Co-authored papers 2
Co-authored papers 2
Rutgers University
Co-authored papers 1
Rensselaer Polytechnic Institute
Co-authored papers 1
Schrodinger Inc.
Co-authored papers 1
Center for Structural Biology of Infectious Diseases, University of Chicago
Co-authored papers 1
European Bioinformatics Institute
Co-authored papers 1
University of California San Diego
Co-authored papers 1
The State University of New Jersey
Co-authored papers 1
The State University of New Jersey
Co-authored papers 1
Institute for Protein Research, Osaka University
Co-authored papers 1
Lawrence Berkeley National Laboratory
Co-authored papers 1
University of Wisconsin-Madison
Co-authored papers 1
The State University of New Jersey
Co-authored papers 1
Cambridge Institute for Medical Research, University of Cambridge
Co-authored papers 1
Co-authored papers 1
Los Alamos National Laboratory
Co-authored papers 1
University of Virginia
Co-authored papers 1
Co-authored papers 1
The State University of New Jersey
Co-authored papers 1
Lexicon Pharmaceuticals
Co-authored papers 1